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Abstract
Aims Atrial fibrillation (AF) and heart failure are conditions
that often coexist. Consequently, many patients with an im-
plantable cardioverter-defibrillator (ICD) present with AF. We
evaluated the effectiveness of internal cardioversion of AF in
patients with an ICD.
Methods Retrospectively, we included 27 consecutive ICD
patients with persistent AF who underwent internal cardiover-
sion using the ICD. When ICD cardioversion failed, external
cardioversion was performed.
Results Patients were predominantly male (89%)with a mean
(SD) age of 65±9 years and left ventricular ejection fraction of
36±17 %. Only nine (33 %) patients had successful internal
cardioversion after one, two or three shocks. The remaining 18
patients underwent external cardioversion after they failed
internal cardioversion, which resulted in sinus rhythm in all.
A smaller left atrial volume (99±36 ml vs. 146±44 ml;
p =0.019), a longer right atrial cycle length (227 (186–255)
vs. 169 (152–183) ms, p =0.030), a shorter total AF history (2
(0–17) months vs. 40 (5–75) months, p =0.025) and dual-coil
ICD shock (75 % vs. 26 %, p =0.093) were associated with
successful ICD cardioversion.
Conclusion Internal cardioversion of AF in ICD patients
has a low success rate but may be attempted in those with
small atria, a long right atrial fibrillatory cycle length and a
short total AF history, especially when a dual-coil ICD is
present. Otherwise, it seems reasonable to prefer external
over internal cardioversion when it comes to termination
of persistent AF.
Keywords Atrial fibrillation . Implantable cardioverter
defibrillator . Internal cardioversion
Introduction
Persistent atrial fibrillation (AF) can be terminated by phar-
macological or electrical cardioversion. Electrical cardiover-
sion is effective in about 86–95 % of patients [1–3].
In patients with an implantable cardioverter-defibrillator
(ICD), AF can be cardioverted with a synchronised internal
shock from the ICD. Only limited data are available on the
efficacy of internal ICD cardioversion for AF [4]. In the
present study, we evaluated the effectiveness of internal car-
dioversion of AF in ICD patients.
Methods
From our prospective electronic ICD database we retrospec-
tively identified 27 patients with persistent AFwho underwent
elective cardioversion using the ICD between 2007 and 2012.
In our hospital, cardioversion by means of ICD is the first
choice in patients with persistent AF who have an ICD.
Persistent AF was defined as an episode of non-self-
terminating AF lasting at least 7 days, confirmed by electro-
cardiography [5]. Peri-cardioversion patients received appro-
priate oral anticoagulation according to the ESC guidelines for
the management of AF [5]. Baseline and procedural charac-
teristics were extracted from medical charts using the hospital
electronic data system. Specifications of ICDs were retrieved
from our ICD database. When available, the atrial fibrillation
cycle length (AFCL) was measured from the intracardiac
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recordings. The average of at least 10 consecutive AFCLs was
used. Recurrence of AF was defined as AF lasting at least 30 s
documented on 12-lead ECG or registered by intracardiac
recordings available from the ICD. LV dimensions, LV ejec-
tion fraction and atrial dimensions was measured according to
the recommendations as described in the American Society of
Echocardiography guidelines. This retrospective analysis was
approved by the local Ethics Committee and complied with
the Declaration of Helsinki.
Procedures
Patients had to be in a fasting state before the procedure. After
sedation (propofol or etomidate), internal cardioversion with
the ICD was performed in all patients. Internal cardioversion
was carried out by the ICD technician in the presence of the
attending physician. An internal biphasic shock was given
synchronised with the ventricular electrogram. If, in case of
failure, a second internal shock was attempted, this was
performed using reversed polarity. All patients received at
least one shock from the ICD using the maximum shock
energy of the device (at least 31 J, range between 31 and
41 J). ICDs were from Medtronic (n =19), Boston Scientific
(n =7), and St. Jude Medical (n =1). The number of shocks
was decided by the attending physician. Success of cardiover-
sion was defined as termination of AF and the presence of two
or more consecutive P waves aftershock documented on the
12-lead surface ECG. If internal cardioversion failed, an ex-
ternal direct current shock synchronised to the ventricular R
wave was performed using a biphasic shock (Lifepak® defi-
brillator, Medtronic Inc, Minnesota, USA) with handheld
paddles or self-adhesive pads in the anterior–posterior posi-
tion with the patient in a left or right lateral recumbent posi-
tion. Shocks were delivered starting at 200 or 360 J stored
energy, decided by the attending physician. If AF persisted,
one additional shock was applied using 360 J. Following
internal and external cardioversion the ICD was interrogated
for changes in sensing threshold, pacing threshold and pacing
impedance.
Statistical analysis
Data analysis was performed using SPSS statistical software
(SPSS, Inc., release 18.0). The Kolmogorov–Smirnov test
was used to test the continuous variables for normal distribu-
tion. The continuous variables are reported as mean ± standard
deviation when normally distributed and as median and
interquartile range (IQR 25th percentile–75th percentile)
when distribution was not normal. Categorical variables are
reported as observed number of patients (percentage). Differ-
ences between parameters with normal distribution were test-
ed with an independent t-test and with abnormal distribution
with the Mann–Whitney test. Fisher’s exact test was used to
compare categorical variables. A p -value of <0.05 was con-
sidered to be statistically significant.
Results
Baseline characteristics
The baseline characteristics are presented in Table 1. Nine of
27 patients were treated with anti-arrhythmic drugs (AAD)
with the majority using amiodarone. Dilated cardiomyopathy
was the main reason for ICD implantation (66 %). Four out of
27 patients had a dual-coil ICD lead. In 2 patients the ICDwas
located in the right pre-pectoral region, in the other patients
the ICD was in the left part. In all patients the shock lead was
placed in the apex of the right ventricle. Echocardiograms
were performed at a median of 5 (IQR 2–12) months before
cardioversion.
Cardioversion efficacy by ICD shock
Cardioversion with the ICD resulted in sinus rhythm in only 9
of 27 patients (33 %). AF was terminated with one shock in
seven patients, with two in one patient and one needed three
shocks (Fig. 1). The median maximum energy delivered by
the ICD for successful cardioversion was 35 (35–38) Joules.
Patients with a failed internal cardioversion received one
(n =9) or two (n =9) shocks by the ICD with a median
maximum shock of 35 (35–36) Joules. In all these 18
patients, external electrical cardioversion resulted in si-
nus rhythm after one or two shocks, in 16 and 2 patients
respectively. The median shock energy for successful cardio-
version was 200 (200–360) joules. No adjustments to the ICD
settings were necessary following interrogations of the ICD
after cardioversion.
Factors associated with successful ICD cardioversion
Patients with successful ICD cardioversion had significantly
smaller left atrial volumes (99±36 ml vs. 146±42 ml;
p =0.019) and a trend towards smaller right atrial volumes
(77 (73–86) ml vs. 104 (77–136) ml, p =0.07) compared
with patients in whom internal cardioversion failed. In
addition, in patients with acute successful internal elec-
trical cardioversion there was a significantly shorter
history of AF (2 (0–17) months vs. 40 (5–75) months,
p =0.025) and a trend to a shorter current episode of AF
(39 (16–133) days vs. 103 (41–182) days p =0.28). Three
out of four patients with a dual-coil ICD had successful
internal electrical cardioversion. Pre-cardioversion atrial
fibrillatory cycle length could be assessed in 16 patients
and was significantly longer in patients with successful con-
version (227 (186–255) vs. 169 (152–183) ms, p =0.030). Of
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the 9 patients using AADs, only 3 (33 %) converted to sinus
rhythm with the ICD compared with 6 of 18 (33 %) patients
not using AADs.
Follow-up
Recurrence of AF after 1 year of follow-up occurred in 18 out
of 27 patients (67 %). There was a trend towards a higher
recurrence rate in the group with failed internal cardioversion
compared with the group who had successful internal
cardioversion (78 % vs. 44 %, p =0.11). There was no differ-
ence in AF cycle length in patients with or without recurrence
(176 (150–203) vs. 172 (158–250) ms, p =0.83) respectively.
The current AF episode duration (prior to ECV) did not differ
significantly between those with and without an AF
recurrence within 1 year (85 (39–133) vs. 102 (20–223) days;
p =0.87) respectively. Furthermore, no significant echo-
cardiographic differences were observed between patients
with and without an AF recurrence during 1-year follow-up
(data not shown).
Table 1 Baseline characteristics of patients who had no conversion to SR after internal ICD shock versus patients who had successful conversion to SR
All N =27 No SR after ICD shock
N =18 (67 %)
SR after ICD shock
N =9 (33 %)
P-value
Age (years) 65±9 65±10 65±8 0.89
Male 24 (89 %) 16 (89 %) 8 (89 %) 1.00
Body surface area (m2) 2.0±0.2 1.9±0.2 2.0±0.2 0.48
Total AF history (months) 22 (3–63) 40 (5–75) 2 (0–17) 0.025
Duration of current AF episode (days) 101 (32–155) 103 (41–182) 39 (16–133) 0.28
Medical history
Hypertension 18 (67 %) 7 (39 %) 2 (22 %) 0.67
Coronary arterial disease 19 (70 %) 14 (78 %) 5 (56 %) 0.38
Diabetes mellitus 5 (19 %) 4 (22 %) 1 (11 %) 0.64
Stroke 0 0 0 1.00
Transient ischaemic attack 2 (7 %) 1 (6 %) 1 (11 %) 1.00
Heart failure 18 (67 %) 12 (67 %) 6 (67 %) 1.00
Medication
Acenocoumarol 27 (100 %) 18 (100 %) 9 (100 %) 1.00
Sotalol 2 (7 %) 1 (6 %) 1 (11 %) 0.53
Amiodarone 7 (26 %) 5 (28 %) 2 (22 %) 1.00
Flecainide 0 0 0 1.00
Beta-blocker 24 (89 %) 16 (89 %) 8 (89 %) 1.00
ACE-inhibitor or ATII-antagonist 21 (78 %) 14 (78 %) 7 (78 %) 1.00
Statin 19 (70 %) 12 (67 %) 7 (78 %) 0.38
Echocardiographic parameters
LVejection fraction (%) 36±17 34±18 40±16 0.39
Diameter LA (mm) 51±6 52±7 49±5 0.29
Volume LA (cc) 132±35 146±44 99±36 0.019
Volume RA (cc) 89 (76–110) 104 (77–136) 77 (73–86) 0.07
LVend-diastolic diameter (mm) 61±10 61±38 59±9 0.62
LVend-systolic diameter (mm) 50±14 51±14 47±12 0.55
ICD details
Indication for ICD
- Non-ischaemic cardiomyopathy 6 (22 %) 3 (17 %) 3 (33 %)
- Post-infarction cardiomyopathy 12 (44 %) 8 (44 %) 4 (44 %)
- Hypertrophic cardiomyopathy 3 (11 %) 2 (11 %) 1 (11 %)
- Unclassified 6 (22 %) 5 (28 %) 1 (11 %)
Single coil 23 (85 %) 17 (94 %) 6 (67 %) 0.09
Atrial cycle length (ms, N =16) 175 (157–211) 169 (152–183) 227 (186–255) 0.030
Results are shown as number (%) or as mean ± SD when equally distributed and as median (interquartile range) when there was no normal distribution
LA left atrium; LV left ventricular; RA right atrium; SR sinus rhythm
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Discussion
The main finding of the present study is that internal cardio-
version by means of ICD shock results in conversion to sinus
rhythm in only one third of patients. Factors associated with
successful conversion in our study include smaller left atrium,
longer right atrial fibrillatory cycle length, shorter total AF
duration and use of dual-coil rather than single-coil ICD
shocks. Our data support the notion that internal cardioversion
of persistent AF in patients with single-coil ICD should be
reserved for patients with a favourable arrhythmia profile.
Factors associated with successful cardioversion with an ICD
Only limited data are available on the cardioversion efficacy
in persistent AF using the ICD. Two studies showed high
cardioversion efficacy of ICD shocks in patients with parox-
ysmal or acutely induced AF [6, 7]. Turco et al. [4] evaluated
cardioversion efficacy of ICD shocks in patients with a
CRT-D device and permanent AF for more than 1 year. They
found that 82 % of patients could be converted to stable sinus
rhythm. The difference with our study concerning conversion
efficacy is remarkable. Patients were very similar concerning
parameters known to be associated with successful cardiover-
sion including AF duration, and left ventricular and atrial
sizes. However, in their study, the conversion procedure was
only performed after at least 3 months of biventricular pacing
which may have optimised atrial electrophysiology before
conversion. In addition, all patients were pretreated with
amiodarone which enhances electrical cardioversion [8, 9].
Also, their cardioversion protocol required as many as 3
shocks before cessation of the cardioversion attempt. Finally,
although not reported in the manuscript [4], all patients had
dual-coil defibrillator leads (personal communication with the
authors). It is well known that the shock vector, deter-
mined by the position of the shock coil(s) and the can
of the ICD, has major impact on shock efficacy. For
defibrillation of ventricular arrhythmias the defibrillation
threshold is, for example, higher when the can is placed
in the right rather than the left sub-pectoral position
[10]. With respect to atrial arrhythmias it was previously
shown that dual-coil shocks are associated with a lower atrial
defibrillation threshold [7]. Electrical cardioversion of AF
with temporary internally placed catheters in the right atrium
and coronary sinus is associated with a high cardioversion
efficacy [11–13]. The internal defibrillation catheters were
encompassing both atria, producing the most ideal shock
vector for atrial defibrillation.
In our study population the majority of patients had a
single-coil shock lead located in the right ventricle. This
resulted in a less ideal shock vector for atrial defibrillation,
which may explain the low cardioversion efficacy. Although
Fig. 1 Flowchart of ICD
cardioversions and external
electrical cardioversion (ECV).
SR denotes sinus rhythm
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the number of patients with dual coils was small in the present
study, cardioversion efficacy was indeed remarkably higher in
patients with a dual coil (75 %, 3 out of 4) compared with
single coil (26 %, 6 out of 23). Worldwide, dual-coil ICD lead
systems are more popular than single-coil ICD systems
[14]. The main reason that the majority in this study
population had a single-coil lead is the difficult extraction
procedure of dual-coil leads due to the location in the proximal
coil [15].
Many other factors may influence acute external cardiover-
sion outcome, including AF duration, atrial size, patient age,
presence of heart failure or structural heart disease, and pre-
treatment with drugs [3, 8, 16–18]. One interesting finding in
the present study was the association between long atrial
fibrillatory cycle length, as measured from an atrial electro-
gram from the atrial pacing lead, and high internal cardiover-
sion efficacy. Shortening of the atrial refractory period and
hence also of the atrial fibrillatory cycle length is associated
with increasing electrophysiological complexity and reduced
response to anti-arrhythmic treatment [19–22]. A short cycle
length may therefore represent an advanced atrial substrate.
This supports the notion that a longer atrial fibrillatory cycle
length as measured from the atrial lead in the device may help
identify AF patients who may respond to internal atrial
defibrillation.
In this study the AF recurrence rate after 1-year follow-up
is comparable with that seen after external cardioversion [23].
This is somewhat surprising since most patients in the present
study had significant structural heart disease with the majority
having reduced systolic LV function a marked atrial dilation.
Interestingly, patients who underwent successful internal car-
dioversion had a recurrence rate of only 44 %. Although the
number of patients is too small to draw a firm conclusion, it is
tempting to speculate that these patients had a less advanced
atrial substrate since they responded to single-coil internal
cardioversion.
Limitations
Although we collected data prospectively in our pacemaker
and ICD database, this study was retrospective and at best
reflects real-life internal cardioversion practice. The majority
of patients had a single-coil ICD hampering drawing conclu-
sions for dual-coil configurations. Nevertheless, the findings
concerning the effects of (single-coil) ICD shocks are note-
worthy, especially since data concerning clinical internal ICD
cardioversion of persistent AF are largely lacking. A
randomised study comparing external cardioversion and ICD
cardioversion with inclusion of more patients would be desir-
able. However, due to the remarkable low success percentage
of internal cardioversion, our protocol has been adapted and
the first choice is external cardioversion for persistent AF in
patients with an ICD.
Clinical implications and conclusion
In patients with an ICD, clinicians are often confronted with
troublesome AF [24–26] which may need cardioversion to
ameliorate symptoms and potentially unfavourable haemo-
dynamics. Currently, there are no guidelines on whether or
not internal atrial defibrillation is appropriate in patients with
an ICD presenting with persistent AF. The present study
suggests that internal ICD shocks are largely ineffective in
this respect, especially in case of single-coil shocks. In the
presence of a single-coil ICD, internal cardioversion may,
however, be considered if patients harbour a favourable ar-
rhythmia profile including smaller atrial volume, longer right
atrial cycle length and shorter AF history. Otherwise, it seems
reasonable to prefer external over internal cardioversion when
it comes to terminating persistent AF. In this way, unnecessary
unsuccessful shocks by the ICD can be prevented and in
addition earlier battery depletion and prolonged sedation du-
ration during cardioversion can be minimised.
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